• ADI-PEG 20 Seen to Improve Response to Chemo in MPM Patients in Extension Trial
  • Phase 3 Clinical Trial to Test Opdivo in Mesothelioma Patients in United Kingdom
  • Aduro, Merck to Begin Clinical Trial Assessing CRS-207, Keytruda Combo to Treat Worsening MPM
  • Yondelis Stabilized Mesothelioma in Many Patients Taking Part in Phase 2 Clinical Trial
  • Bristol-Myers Squibb Recruits Patients for Phase 3 Trial Testing Opdivo-Yervoy Combo to Treat MPM
  • High Mesothelin Levels Linked to Poor Prognosis in Malignant Pleural Mesothelioma Patients, Study Reports
  • Duration of Asbestos Exposure Influences Risk of Pleural Mesothelioma
  • Mesothelin Protein Expression Can Help Predict Mesothelioma Patients’ Survival, Study Reports
  • TTFields, Which Alternates Forms of Electricity to Kill Mesothelioma Cells, Obtains an FDA Sign-off
  • Simultaneous Inhibition of Two Cell Pathways Prevents Mesothelioma Tumor Growth, Study Finds
  • Study Identifies Blood Biomarkers for Diagnosing Early MPM
  • Intensity-modulated Radiotherapy May Be Safer, More Effective in Treating Mesothelioma